Loading
Life sciences · Journal article
npj Imaging · November 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The complex tumor microenvironment and tumor heterogeneity make treatment responses highly variable, driving the shift toward biomarker-based therapy prediction. Ultrasound shear wave elastography (SWE) provides a simple and non-invasive method to measure tissue mechanical properties, such as tumor stiffness, by tracking shear wave propagation speed. Increased tumor stiffness is closely associated with compression of intratumoral blood vessels, which can severely limit blood flow within solid tumors, causing hypo-perfusion and hypoxia. These two abnormalities, in turn, hinder effective drug delivery and induce immunosuppression, which compromise the efficacy of cancer therapies. Tumor perfusion can be evaluated using contrast-enhanced ultrasound (CEUS), a minimally invasive imaging technique that employs microbubble contrast agents alongside ultrasound imaging to visualize blood flow and quantify tissue perfusion. In this study, we first developed CNN-ultra, a convolutional neural network trained separately on SWE and CEUS images to predict tumor response to chemo-immunotherapy in murine models of breast cancer, sarcoma, and melanoma. The dataset consisted of 587 SWE and CEUS images acquired prior to chemo-immunotherapy and tumor response was classified as responsive, stable, or non-responsive according to Response Evaluation Criteria in Solid Tumors (RECIST) adapted to volumetric changes (175 responsive, 136 stable, and 276 non-responsive cases). The overall accuracy of CNN-ultra was 0.877 for the SWE images and 0.825 for the CEUS images. Subsequently, we developed CNN-combi, an integrated model designed to combine features from both SWE and CEUS images to enhance predictive performance. Our CNN-combi model achieved an overall test accuracy of 0.930, with class-specific accuracies of 0.983 for responsive, 0.930 for stable and 0.947 for non-responsive tumors. These findings provide preclinical evidence of predictive performance and support the potential of combining SWE and CEUS as imaging biomarkers for predicting therapeutic response.